Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Cash back taxes can be confusing. This guide provides essential insights to help you navigate your tax responsibilities.
22,480 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
TD Bank has been on investors' radars, but sustained upside hinges on three core drivers. Explore how regulatory shif...
CrowdStrike accelerates an acquisition push as Palo Alto Networks doubles down on platform strategy. Both leaders rep...
By 2035, millions of small and medium businesses face ownership changes, potentially unlocking up to $5 trillion in v...
Global markets pulled back after Iran strikes sparked a heated political response. Investors weigh consequences for s...
Bank of America issues two contrasting Buy ratings, backing Tesla’s autonomy roadmap and GM’s truck-led profitability...
A large fund trimmed its DigitalBridge position, sparking questions about stake moves, stock momentum, and how invest...
A fresh settlement involving Ticketmaster sparked a rally in Live Nation shares, signaling investor relief but stirri...
Long-term investors chase multibagger dreams. This article explores a high-potential biotech setup with 26 late-stage...
Public financing is reshaping homebuilding profitability, with front-end agreements dictating costs and returns as di...
Two widely watched real estate ETFs take different paths to property exposure. This gqre icf: matchup real guide comp...
Tesla posts stronger margins amid a delivery dip, while Rivian turns profitable on software and a hopeful R2 ramp. An...